INJECTABLE MOISTURISER SINGAPORE

The Humble Guide to Hyaluronic Acid Treatment for Hydration, Smoothness and Radiance

1 simple boost,
up to 9 months of
hydrated* and radiant skin**

✔ Hydration

✔ Smoothness

✔ Radiance

Injectable Moisturiser Singapore:
Hyaluronic Acid HA Microdroplets

For patients in Singapore looking for more than a topical moisturiser but who do not want a volumising filler, an injectable moisturiser occupies a distinct position within medical aesthetics. It is particularly relevant for skin that appears dehydrated, dull, rough or less smooth, where the primary objective is improvement in skin quality rather than alteration of facial structure.

Clinical studies of an intradermal hyaluronic acid microdroplet formulation have demonstrated improvements in cheek skin smoothness, skin hydration and patient-reported satisfaction, with objective hydration measurements remaining improved through follow-up at nine months in a prospective study. [1–3]

What Is an Injectable Moisturiser?

An injectable moisturiser is a descriptive term for an intradermal injectable treatment intended primarily to improve skin hydration and other superficial skin-quality attributes.

Hyaluronic acid is a naturally occurring glycosaminoglycan found within the extracellular matrix of skin. One of its important biological properties is its ability to bind and retain water. When hyaluronic acid is delivered intradermally in a formulation designed for skin-quality treatment, it can provide a local reservoir of hyaluronic acid within the skin rather than simply applying a moisturising ingredient to the skin surface.

This creates an important distinction between three commonly confused treatment concepts:

Topical Moisturiser

Applied on skin surface

Injectable Moisturiser

Applied on skin surface

Dermal

Filler

Deeper placement

Hydrates the surface

Improves skin barrier

Hydration + smoothness

Improves skin quality

Restores volume

Enhances facial contour

TOPICAL MOISTURISER

Primary objective: Surface hydration and barrier comfort

Typical clinical focus: Daily dryness, tightness and rough surface texture

INJECTABLE MOISTURISER

Primary objective: Hydration and smoothness

Typical clinical focus: Dehydrated-looking skin, superficial texture, fine lines and radiance

DERMAL FILLER

Primary objective: Volume and contour

Typical clinical focus: Volume loss, structural support and facial contouring

These categories can overlap because hyaluronic acid is used in many different formulations from topical to injectable.

The formulation, concentration, rheological properties, injection depth and intended clinical objective all influence how an injectable should be used.

Why Does Skin Hydration Matter?

Skin quality is multidimensional. It encompasses how the skin looks, feels and moves.

Visible characteristics can include radiance, redness and pigmentation. Surface and tactile characteristics include dryness, roughness and fine lines, while mechanical characteristics include elasticity, sagging and crepiness.

Hydration is an important component of skin quality

Although patients have various options to improve skin quality, there is a big opportunity for a treatment that can provide long lasting, deep hydration in one session*.

Hydration is an important component of this overall picture. Reduced skin hydration can contribute to dryness, roughness and an uneven or dull appearance. Improving hydration can therefore influence the way skin looks and feels without necessarily changing facial volume or contour.

This is why an injectable moisturiser can be considered a treatment for skin quality rather than simply a treatment for wrinkles.

How Long Does an Injectable Moisturiser Last?

Up to 9 months

Objective skin hydration was followed through Month 9 in a prospective clinical study.

91%

of patients were happier with their skin at Month 1 compared with baseline.

76%

remained happier with their skin at Month 9 compared with baseline.

In the prospective clinical programme, skin hydration was measured instrumentally at different depths and followed through Months 1, 4, 6 and 9. Improvements in measured cheek hydration remained evident through the Month 9 assessment. [2]

Patient-reported outcomes also demonstrated persistence over time. Ninety-one percent of patients reported being happier with their skin at Month 1 compared with baseline, while 76% remained happier with their skin at Month 9. [3]

How Does an Injectable Moisturiser Work?

The principal ingredient in this type of treatment is hyaluronic acid (HA), a naturally occurring molecule with a high capacity for binding water.

When administered as small intradermal microdroplets, HA is positioned within the superficial layers of the skin. Its water-binding properties contribute to the local hydration environment, while clinical studies have demonstrated measurable changes in skin hydration and smoothness following treatment.

Hyaluronic acid is not simply a passive moisturising ingredient. It is an important component of the extracellular matrix and interacts with the surrounding tissue environment. Experimental work involving intradermal treatment has also demonstrated changes in skin hydration, firmness, epidermal aquaporin-3 (AQP3) expression and markers related to extracellular matrix biology. [4]

HOW HYALURONIC ACID HYDRATES SKIN

A closer look at the science

Hyaluronic acid has a strong capacity to bind water

Intradermal hyaluronic acid helps retain water in the skin leading to improved hydration

Aquaporin-3 (AQP3) is involved in epidermal water and glycerol transport, which also contributes to skin hydration,

What Is Aquaporin-3 and Why Is It Relevant to Skin Hydration?

Aquaporin-3 (AQP3) is a membrane channel expressed in epidermal cells that facilitates the movement of water and glycerol. It is involved in epidermal hydration and skin homeostasis.

Experimental research has identified changes in AQP3 expression following intradermal hyaluronic acid treatment, providing one possible biological mechanism contributing to changes in skin hydration. [4]

What Can an Injectable Moisturiser Improve?

The most relevant treatment objectives are improvements in selected superficial skin-quality attributes rather than facial reshaping.

Skin hydration — improvement in measured and perceived skin hydration.
Skin smoothness — improvement in the surface quality and smoothness of the treated skin.
Fine superficial lines — reduction in the appearance of selected fine cutaneous lines.
Radiance — patients may perceive the skin as more radiant and refreshed.
Healthy-looking appearance — improvement in overall satisfaction with the appearance of the skin.

Injectable Moisturiser-skinvive-results.png

The strongest clinical evidence relates to cheek skin smoothness and hydration. Improvements in radiance and healthy-looking skin are supported by patient-reported outcome measures rather than being equivalent to an objective measurement of skin hydration.

Clinical Evidence for Injectable Hyaluronic Acid

The clinical evidence is more substantial than a simple before-and-after photograph. Multiple prospective studies have evaluated intradermal hyaluronic acid treatment using objective skin measurements, investigator assessments and validated patient-reported outcomes.

CLINICAL EVIDENCE

Robust studies with up to 9 months of follow-up

A Randomised, Evaluator-Blinded Study

A multicentre randomised, evaluator-blinded study evaluated intradermal treatment for cheek skin smoothness, fine lines and hydration. A total of 209 participants were randomised, with treatment compared against a delayed-treatment control group.

The study assessed investigator-rated cheek smoothness and fine lines together with instrument-measured skin hydration. The treatment produced significant improvements in the assessed skin-quality outcomes, supporting its use as an intradermal treatment for improving cheek skin smoothness. [1]

The US FDA subsequently approved the treatment for intradermal injection to improve facial skin smoothness of the cheeks in adults aged 21 years and older, based on this clinical programme. [5]

Prospective Study of Skin Hydration and Skin Quality

A separate prospective study evaluated 131 participants treated with intradermal in the cheeks and forehead, with the option of treating the neck. Skin hydration and skin roughness were assessed over time using objective measurements.

A subset of participants received a touch-up treatment approximately 30 days after the initial treatment when required. The study followed participants through nine months after the last treatment and demonstrated sustained improvements in measured skin hydration and skin-quality parameters. [2]

What Do Patients Notice After Treatment?

Patient-reported outcomes provide an important complement to objective measurements. In a prospective study using selected components of the validated FACE-Q Satisfaction With Skin questionnaire, patients reported improvements in several aspects of facial skin appearance following treatment.

Happier with their skin

40% at baseline → 91% at Month 1 → 76% at Month 9

Radiant

27% at baseline → 82% at Month 1 → 63% at Month 9

Hydrated

40% at baseline → 84% at Month 1 → 71% at Month 9

Healthy-looking

55% at baseline → 87% at Month 1 → 76% at Month 9

At Month 9, 86.6% of responding patients reported that they would recommend the treatment to a friend. [3]

Does an Injectable Moisturiser Add Facial Volume?

Conventional dermal fillers are commonly used to restore volume, provide structural support or alter facial contours. An injectable moisturiser uses a different treatment concept, with small intradermal deposits intended primarily to improve skin-quality attributes such as hydration and smoothness.

This makes the treatment particularly relevant for patients who want their skin to look more hydrated, smooth and refreshed without intentionally changing the overall shape of the face.

Who May Benefit From an Injectable Moisturiser?

An injectable moisturiser may be considered for adults whose primary concerns relate to skin quality rather than facial volume.

Dehydrated-looking skin
Dull or tired-looking skin
Loss of skin smoothness
Fine superficial lines
Rough or uneven skin texture
Reduced radiance
A desire for healthier-looking skin without intentional facial contouring

The treatment is not intended to correct every cause of facial ageing. Pigmentation, acne scarring, significant laxity, deeper wrinkles, volume loss and structural changes may require other treatments or a combination approach.

Injectable Moisturiser vs Skin Booster: What Is the Difference?

The terms “injectable moisturiser” and “skin booster” are sometimes used interchangeably in aesthetic medicine, but they are not necessarily describing the same treatment objective.

An injectable moisturiser is best understood as a descriptive term emphasising hydration and superficial skin smoothness. The term skin booster is broader and may refer to a range of injectable treatments intended to improve overall skin quality, including hydration, elasticity, firmness and other features of skin ageing.

The appropriate treatment therefore depends on the patient's main concern.

If your main concern is dehydration, dullness and superficial roughness
→ a treatment focused on hydration and skin smoothness

If your main concern is broader changes in elasticity, firmness or skin ageing
→ a treatment focused on skin-quality improvement or bio-remodelling

If your main concern is loss of facial volume or contour
→ a treatment focused on structural dermal filler treatment

Where the primary concern is elasticity, firmness or laxity rather than hydration, a skin booster and bio-remodelling treatment may be the more appropriate option.

Injectable Moisturiser vs Dermal Filler

Although both treatments may contain hyaluronic acid, they should not be considered interchangeable.

Dermal fillers are formulated and injected according to their intended tissue plane and rheological properties to provide volume, projection, contour or structural support. An injectable moisturiser is administered intradermally in small deposits with the primary objective of improving skin-quality attributes.

How Is an Injectable Moisturiser Administered?

The treatment involves multiple small intradermal injections or microdroplets placed within the selected treatment area. The exact injection pattern, volume and anatomical distribution should be determined by a trained medical practitioner according to the formulation being used and the patient's skin characteristics.

The formulation used in the clinical studies contained lidocaine to improve comfort during injection.

Because the treatment involves numerous superficial injections, temporary pinpoint swelling, redness or small raised areas can occur immediately afterwards.

Is an Injectable Moisturiser Painful?

Discomfort varies between individuals and depends on the treatment area, injection technique and individual pain sensitivity. The formulation evaluated in the clinical studies contains lidocaine, a local anaesthetic intended to reduce discomfort during injection.

Topical anaesthesia may also be considered depending on the patient's preference and the clinical protocol. Most discomfort is associated with the individual needle punctures rather than the hyaluronic acid itself.

Downtime and Recovery

Temporary effects can include:

Redness
Swelling or oedema
Tenderness
Bruising
Small raised areas at injection sites
Induration or small nodules

In a prospective clinical study, patients recorded whether they had returned to normal daily social activities during the first three days after treatment. This provides evidence that the treatment was designed around limited short-term disruption, although individual recovery varies. [3]

Patients should follow the specific post-treatment instructions provided by their medical practitioner and should seek review if symptoms are severe, persistent or unexpected.

Side Effects and Safety

Like all injectable treatments, intradermal hyaluronic acid carries risks. Common or expected injection-site reactions may include redness, swelling, erythema, bruising, tenderness and temporary induration or nodules.

Other possible local reactions include staining or discolouration at the injection site. The full safety profile depends on the specific formulation and should be discussed with the treating practitioner before treatment.

Who Should Not Have an Injectable Moisturiser?

Suitability should be assessed medically before treatment. The Singapore product information supplied for the formulation used in the clinical evidence identifies a number of situations in which treatment should not be performed.

These include known hypersensitivity to hyaluronic acid, hypersensitivity to relevant bacterial proteins used in production, or hypersensitivity to lidocaine or amide-type local anaesthetics. Treatment is also contraindicated in certain medical circumstances and should not be performed through areas with active inflammatory or infectious skin conditions such as active acne or herpes.

The product information also specifies restrictions relating to pregnancy, breastfeeding and paediatric use, as well as other medical conditions. The complete Directions for Use should be reviewed by the treating practitioner before treatment.

Can Injectable Moisturiser Be Combined With Other Aesthetic Treatments?

An injectable moisturiser can form part of a broader aesthetic treatment plan when clinically appropriate. Published clinical experience has described its use alongside other aesthetic modalities, including botulinum toxin, dermal fillers, skin-tightening procedures and complexion-based energy devices.

At Nee Soon Clinic the treatments most often considered alongside an injectable moisturiser are botulinum toxin treatment for lines caused by muscle movement, HIFU non-surgical face lifting where tightening is the objective, and INDIBA radiofrequency therapy as a needle-free option.

However, combination treatment requires appropriate sequencing.

The correct interval between procedures should therefore be determined by the treating practitioner according to the procedure performed, degree of inflammation and condition of the skin.

How Many Sessions Are Needed?

A major feature of the clinical evidence is that meaningful outcomes were demonstrated following an initial treatment, with a subset of patients receiving a touch-up approximately 30 days later when required.

This does not mean that every patient requires a fixed course of multiple sessions. Treatment frequency should be individualised according to baseline skin quality, clinical response and treatment goals.

Because the clinical evidence demonstrated persistence of measured hydration through nine months, maintenance treatment does not necessarily need to follow a short, fixed interval for every patient.

When Will I See Results?

Some patients notice improved hydration and skin appearance relatively early after treatment, while the clinical assessment of skin-quality outcomes is generally performed over subsequent weeks and months.

Clinical studies demonstrated measurable improvements in hydration and skin-quality parameters during follow-up, while patient-reported satisfaction was particularly high at Month 1 and remained above baseline at Month 9. [2,3]

The visible result is therefore not simply the immediate effect of swelling or injected fluid. The intended outcome is improvement in the underlying appearance and quality of the treated skin over time.

Is an Injectable Moisturiser Suitable for Dry Skin?

Dry-looking skin and dehydrated skin are not always the same problem.

An injectable hyaluronic acid treatment primarily addresses skin hydration rather than replacing a comprehensive skincare routine. Patients with significant dryness, irritation or barrier dysfunction may require appropriate topical skincare and treatment of the underlying cause before considering an injectable procedure.

A medical assessment can help distinguish dehydration from conditions such as eczema, dermatitis, inflammatory acne or other causes of dryness.

Injectable Moisturiser for Asian Skin

Skin response varies between individuals and should not be predicted solely from ethnicity or skin colour. The clinical evidence included participants across a range of Fitzpatrick skin types, with the largest groups represented by Fitzpatrick III and IV in the pivotal study.

For Asian patients, treatment should still be individualised according to skin type, pigmentation tendency, inflammation, previous treatment history and the specific condition of the skin at the time of injection.

What Makes an Injectable Moisturiser Different?

The key distinction is the treatment objective.

A conventional moisturiser works primarily at the skin surface. A dermal filler is generally selected when structural volume or contour is required. A broader skin-booster treatment may target multiple aspects of skin quality.

An injectable moisturiser sits between these concepts as a targeted intradermal approach for patients whose main objective is hydrated, smoother, more radiant-looking skin without intentional facial volumisation.

That makes it particularly relevant for patients who feel that their skin looks tired or dehydrated even though their facial volume and contours are satisfactory.

Cost of Injectable Moisturiser in Singapore

The cost of injectable moisturiser treatment in Singapore varies according to the formulation used, amount required, treatment area, medical assessment and whether follow-up treatment is recommended.

A meaningful price comparison should therefore consider more than the injection itself. Medical assessment, treatment planning, product quantity, injection technique, follow-up and management of any treatment-related concerns all form part of responsible medical aesthetic care.

Choosing the Right Injectable Treatment for Your Skin

There is no single injectable treatment that is ideal for every skin concern.

IF YOUR MAIN PROBLEM IS

If the main problem is dehydration, dullness, roughness or loss of smoothness, an injectable moisturiser may be appropriate.

IF YOUR CONCERN IS

If the concern is broader skin ageing, elasticity, firmness or laxity, a skin-booster or bio-remodelling approach may be considered instead.

IF THE PRIMARY ISSUE IS

If the primary issue is volume loss or facial contour, a conventional dermal filler may be more appropriate.

The role of a medical aesthetic consultation is to determine which treatment objective matches the patient's anatomy, skin condition and expectations.

Medical Injectable Moisturiser Treatment at Nee Soon Clinic

At Nee Soon Clinic, injectable skin treatments are approached as medical procedures rather than simply cosmetic products.

A consultation allows the doctor to assess skin quality, hydration, texture, fine lines, facial anatomy, previous aesthetic treatments, medical history and individual treatment goals before recommending an appropriate approach.

Where an injectable moisturiser is appropriate, treatment can be planned around the patient's skin condition and desired outcome, with attention to injection technique, treatment areas, comfort, recovery and follow-up.

The objective is not to change the shape of the face, but to improve the quality and appearance of the skin in a controlled and medically appropriate way.

References

Niforos F, et al. VYC-12 injectable gel for improvement of facial skin topography: a prospective study. Clinical, Cosmetic and Investigational Dermatology. 2019;12:791–798.
Alexiades M, et al. A Randomized, Multicenter, Evaluator-blind Study to Evaluate the Safety and Effectiveness of VYC-12L Treatment for Skin Quality Improvements. Dermatologic Surgery. 2023;49(7):682–688.
Ogilvie P, et al. Improvements in satisfaction with skin after treatment of facial fine lines with VYC-12 injectable gel: patient-reported outcomes from a prospective study. Journal of Cosmetic Dermatology. 2020;19(5):1065–1070.
Safa M, et al. A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers. Clinical, Cosmetic and Investigational Dermatology. 2022;15:411–426.
U.S. Food and Drug Administration. Premarket Approval Supplement P110033/S059: Intradermal injection to improve facial skin smoothness of the cheeks in adults aged 21 years and older.
Ogilvie P, et al. Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines. Clinical, Cosmetic and Investigational Dermatology. 2020;13:267–274.
References from official site https://www.skinvivebyjuvederm.com/

Disclaimer:
The information provided in this article is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. The content is not intended to be a comprehensive source of information and should not be relied upon as such. Reliance on any information provided in this article is solely at your own risk. The authors and the publisher do not endorse or recommend any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned in the article. Any reliance on the information in this article is solely at the reader's own risk.